Jonathan Melamed

53.5k total citations · 3 hit papers
254 papers, 12.2k citations indexed

About

Jonathan Melamed is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jonathan Melamed has authored 254 papers receiving a total of 12.2k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Pulmonary and Respiratory Medicine, 82 papers in Molecular Biology and 46 papers in Surgery. Recurrent topics in Jonathan Melamed's work include Prostate Cancer Treatment and Research (74 papers), Prostate Cancer Diagnosis and Treatment (60 papers) and Urologic and reproductive health conditions (35 papers). Jonathan Melamed is often cited by papers focused on Prostate Cancer Treatment and Research (74 papers), Prostate Cancer Diagnosis and Treatment (60 papers) and Urologic and reproductive health conditions (35 papers). Jonathan Melamed collaborates with scholars based in United States, Uruguay and China. Jonathan Melamed's co-authors include Andrew B. Rosenkrantz, Samir S. Taneja, Herbert Lepor, O. Trujillo‐Cenóz, James S. Babb, Peng Lee, Xiangtian Kong, Fang-Ming Deng, O. Trujillo-Cen�z and Fang‐Ming Deng and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Jonathan Melamed

251 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chemokine Signaling via the CXCR2 Receptor Reinforces Senescence

2008 1.4k citations Jonathan Melamed, Eva Hernando et al. profile →
A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth

2009 698 citations Zhiyong Guo, Xi Yang et al. Cancer Research profile →
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma

2020 388 citations Jonathan Melamed et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan Melamed United States	59	6.0k	4.2k	1.9k	1.9k	1.6k	254	12.2k
Caterina Giannini United States	76	5.1k 0.8×	5.1k 1.2×	1.9k 1.0×	2.5k 1.3×	2.5k 1.5×	398	19.8k
Dominique Figarella‐Branger France	61	3.3k 0.6×	6.1k 1.4×	2.5k 1.3×	1.7k 0.9×	2.9k 1.8×	421	19.3k
Lawrence D. True United States	61	8.0k 1.3×	6.1k 1.4×	1.2k 0.6×	3.5k 1.9×	3.3k 2.0×	277	15.9k
David G. Kirsch United States	53	3.8k 0.6×	6.1k 1.4×	1.7k 0.9×	4.1k 2.2×	2.5k 1.5×	263	13.3k
Ho‐Keung Ng Hong Kong	52	2.6k 0.4×	5.6k 1.3×	1.8k 1.0×	1.7k 0.9×	2.9k 1.7×	340	16.1k
Allen M. Gown United States	68	3.8k 0.6×	5.0k 1.2×	1.5k 0.8×	6.4k 3.4×	3.7k 2.2×	191	16.1k
Giovanni Tallini Italy	65	3.2k 0.5×	4.5k 1.1×	752 0.4×	3.7k 2.0×	2.4k 1.5×	288	14.6k
Sven Perner Germany	55	6.9k 1.2×	6.5k 1.5×	1.0k 0.5×	3.1k 1.7×	3.8k 2.3×	269	12.9k
Jiaoti Huang United States	72	8.2k 1.4×	7.3k 1.7×	1.7k 0.9×	4.3k 2.3×	3.8k 2.3×	308	16.4k
Rohit Mehra United States	49	8.2k 1.4×	7.2k 1.7×	920 0.5×	2.7k 1.4×	4.1k 2.5×	214	13.8k

Countries citing papers authored by Jonathan Melamed

Since Specialization

Citations

This map shows the geographic impact of Jonathan Melamed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Melamed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Melamed more than expected).

Fields of papers citing papers by Jonathan Melamed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Melamed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Melamed. The network helps show where Jonathan Melamed may publish in the future.

Co-authorship network of co-authors of Jonathan Melamed

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Melamed. A scholar is included among the top collaborators of Jonathan Melamed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Melamed. Jonathan Melamed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pu, Tianjie, Jinglong Zhang, Jingrui Chen, et al.. (2024). Stromal-derived MAOB promotes prostate cancer growth and progression. Science Advances. 10(6). eadi4935–eadi4935. 11 indexed citations

Jones, Derek, et al.. (2023). Stimulated Raman histology, a novel method to allow for rapid pathologic examination of unprocessed, fresh prostate biopsies. The Prostate. 83(11). 1060–1067. 5 indexed citations

Kenigsberg, Alexander P., Tsutomu Tamada, Andrew B. Rosenkrantz, et al.. (2017). Multiparametric magnetic resonance imaging identifies significant apical prostate cancers. British Journal of Urology. 121(2). 239–243. 14 indexed citations

Lee, Joo‐Hyung, Sang Hyuk Lee, Sung‐Im Do, et al.. (2016). TPL2 Is an Oncogenic Driver in Keratocanthoma and Squamous Cell Carcinoma. Cancer Research. 76(22). 6712–6722. 19 indexed citations

Liang, Jiaqian, Yirong Li, Garrett Daniels, et al.. (2015). LEF1 Targeting EMT in Prostate Cancer Invasion Is Regulated by miR-34a. Molecular Cancer Research. 13(4). 681–688. 78 indexed citations

He, Feng, Jonathan Melamed, Moon‐shong Tang, Chuanshu Huang, & Xue‐Ru Wu. (2015). Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53 -Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas. Cancer Research. 75(10). 2017–2028. 25 indexed citations

Daniels, Garrett, Yi‐Rong Li, Lan L. Gellert, et al.. (2013). TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth. Endocrine Related Cancer. 21(1). 127–142. 33 indexed citations

Ren, Qinghu, Liying Zhang, Rachel Ruoff, et al.. (2013). Expression of androgen receptor and its phosphorylated forms in breast cancer progression. Cancer. 119(14). 2532–2540. 21 indexed citations

Shibahara, Kotaro, et al.. (2012). Production of Gastrointestinal Tumors in Mice by Modulating Latent TGF-β1 Activation. Cancer Research. 73(1). 459–468. 16 indexed citations

10.

Zhang, Qiuyang, Sen Liu, Dongxia Ge, et al.. (2012). Interleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models. Cancer Research. 72(10). 2589–2599. 85 indexed citations

11.

Liu, Xiaomei, Enrique Carrillo de Santa Pau, Pamela D. Unger, et al.. (2012). KLF6 Loss of Function in Human Prostate Cancer Progression Is Implicated in Resistance to Androgen Deprivation. American Journal Of Pathology. 181(3). 1007–1016. 23 indexed citations

12.

Wei, Jian‐Jun, Xinyu Wu, Yi Peng, et al.. (2010). Regulation of HMGA1 Expression by MicroRNA-296 Affects Prostate Cancer Growth and Invasion. Clinical Cancer Research. 17(6). 1297–1305. 67 indexed citations

13.

Dai, Bojie, Hege Chen, Shengjie Guo, et al.. (2010). Compensatory Upregulation of Tyrosine Kinase Etk/BMX in Response to Androgen Deprivation Promotes Castration-Resistant Growth of Prostate Cancer Cells. Cancer Research. 70(13). 5587–5596. 53 indexed citations

14.

Ligr, Martin, Yi‐Rong Li, Xuanyi Zou, et al.. (2010). Tumor Suppressor Function of Androgen Receptor Coactivator ARA70α in Prostate Cancer. American Journal Of Pathology. 176(4). 1891–1900. 27 indexed citations

15.

Guo, Zhiyong, Xi Yang, Feng Sun, et al.. (2009). A Novel Androgen Receptor Splice Variant Is Up-regulated during Prostate Cancer Progression and Promotes Androgen Depletion–Resistant Growth. Cancer Research. 69(6). 2305–2313. 698 indexed citations breakdown →

16.

Zhang, Yuexing, Douglas E. Linn, Zhenqiu Liu, et al.. (2008). EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance. Molecular Cancer Therapeutics. 7(10). 3176–3186. 51 indexed citations

17.

Dai, Bojie, Oekyung Kim, Yingqiu Xie, et al.. (2006). Tyrosine Kinase Etk/BMX Is Up-regulated in Human Prostate Cancer and Its Overexpression Induces Prostate Intraepithelial Neoplasia in Mouse. Cancer Research. 66(16). 8058–8064. 43 indexed citations

18.

Melamed, Jonathan, et al.. (2005). Abstracts for parallel symposia A-T. Cytometry. 10(S4). 9–44. 1 indexed citations

19.

Kramer, E., Leonard Liebes, Carolyn Wasserheit, et al.. (1998). Initial clinical evaluation of radiolabeled MX-DTPA humanized BrE-3 antibody in patients with advanced breast cancer.. PubMed. 4(7). 1679–88. 29 indexed citations

20.

Charny, Caleb K., et al.. (1995). Sinus histiocytosis mimicking metastatic melanoma in lymph nodes of a patient with a large joint prosthesis: Case report and review of the literature. Journal of Surgical Oncology. 60(2). 128–130. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact